# OnCo record compugen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/compugen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "compugen" ;
  schema:name "Compugen"@en ;
  schema:alternateName "Compugen Ltd"@en, "Compugen Ltd."@en ;
  schema:description "An Israeli company that looks for new immune checkpoints in silico first and only then in the laboratory. It found PVRIG that way, and the antibody against it is in trials; its TIGIT antibody sits inside AstraZeneca's bispecific."@en ;
  schema:url <https://onco.cc/companies/compugen/>, <https://www.cgen.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Compugen_(company)> ;
  schema:citation <https://www.cgen.com>, <https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001119774&type=20-F> ;
  schema:addressCountry "IL" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/ai-drug-design/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/pvrig/>, <https://onco.cc/targets/tigit/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/rilvegostomig/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/>, <https://onco.cc/companies/gilead/> ;
  onco:trials <https://onco.cc/trials/nct06888921/> .